CAS 1189481-51-3
:Elacridar-d4
Description:
Elacridar-d4 is a deuterated form of Elacridar, a compound primarily known for its role as a potent inhibitor of P-glycoprotein (P-gp), which is involved in drug transport and multidrug resistance in cancer therapy. The deuteration (indicated by the "d4" suffix) refers to the substitution of hydrogen atoms with deuterium, a stable isotope of hydrogen, which can enhance the compound's pharmacokinetic properties and stability during metabolic processes. Elacridar-d4 retains the structural characteristics of its parent compound, featuring a complex molecular framework that allows it to effectively interact with P-gp. This modification can also aid in tracing and studying the compound's behavior in biological systems through techniques such as mass spectrometry. Overall, Elacridar-d4 is significant in research focused on overcoming drug resistance in cancer treatments and improving the bioavailability of therapeutic agents.
Formula:C34H33N3O5
InChI:InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)/i14D2,16D2
InChI key:InChIKey=OSFCMRGOZNQUSW-RCYYZLFTSA-N
SMILES:C(NC1=CC=C(C(C(N2CC=3C(CC2)=CC(OC)=C(OC)C3)([2H])[2H])([2H])[2H])C=C1)(=O)C4=C5C(C(=O)C=6C(N5)=C(OC)C=CC6)=CC=C4
Synonyms:- GF 120918-d4
- N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl-d4]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide
- 5-Methoxy-9-oxo-N-[4-[1,1,2,2-tetradeuterio-2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-10H-acridine-4-carboxamide
- GW 0918-d4
- Elacridar-d4
- GG 918-d4
- 5-methoxy-9-oxo-N-[4-[1,1,2,2-tetradeuterio-2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-10H-acridine-4-carboxamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Elacridar-d4 (Major)
CAS:Controlled Product<p>Applications A prototypical BCRP inhibitor. Inhibits the Bcrp1-mediated transport.<br>References Neville, K., et al.: Clin. Cancer Res., 10, 2525 (2004), Reardon, D., et al.: J. Clin. Oncol. 23, 9359 (2005), Pan, G., et al.: Drug Metab. Dispos., 35, 1165 (2007).<br></p>Formula:C34H29D4N3O5Color and Shape:Light Yellow To YellowMolecular weight:567.67Elacridar-d4
CAS:<p>Please enquire for more information about Elacridar-d4 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>Formula:C34H33N3O5Purity:Min. 95%Molecular weight:567.7 g/mol

